Shandong Weigao Group Medical Polymer Company Limited (01066) published a Next Day Disclosure Return dated 19 January 2026, detailing a share repurchase executed on the same date. The number of repurchased H shares totaled 615,200, equating to approximately 0.0137% of the issued shares before the transaction.
After this repurchase, the total issued shares (excluding treasury shares) stood at 4,484,909,524, while treasury shares increased to 37,422,800. The aggregate consideration paid amounted to HKD 3,207,240, with the highest repurchase price at HKD 5.25 per share and the lowest at HKD 5.18 per share.
According to the document, the company had been authorized to repurchase up to 451,560,392 shares, and as of 19 January 2026, a total of 30,774,400 shares had been repurchased under this mandate. The current repurchased shares are being held as treasury shares rather than cancelled.
Comments